Cipro and Doxy

The Department of Health and Human Services (DHHS) Supply Service Center in Perry Point, Maryland is seeking sources for two pharmaceutical products: Isoniazid 300mg in bottles of 30 units and Rifampin 300mg in bottles of 60 units. This pre-solicitation notice indicates the federal government's intent to procure these tuberculosis medications and invites potential suppliers to express interest before the formal solicitation is released. Suppliers should note that products must have the longest possible dating to meet government requirements for stock maintenance and shelf-life management. The procurement falls under the Pharmaceutical and Medicine Manufacturing category (NAICS 3254) and the Drugs and Biologicals PSC category (6505). Interested parties should prepare to submit responses by the April 27, 2026 deadline, with the pre-solicitation notice posted on April 7, 2026.

This contract opportunity is designated as a Total Small Business set-aside, restricting competition to small business entities as defined by the Small Business Administration. The DHHS is seeking to procure a substantial quantity of both medications, with orders totaling 7,500 bottles of Isoniazid and 7,500 bottles of Rifampin to support government health programs and stockpiling initiatives. While specific budget information and award values are not detailed in this pre-solicitation notice, the large quantity requirements suggest a significant procurement that will likely result in a substantial contract award. No incumbent contractor information is provided in this notice; therefore, this may represent a new procurement or the opening of a previously awarded contract to broader competition. Small business contractors interested in supplying these critical pharmaceutical products should monitor for the full solicitation release and begin preparing their capability statements and pricing proposals in advance of the formal bidding period.